Because of selective expression in tumor but not normal tissues, for over a decade, BIRC5 has drawn considerable attention as a potential novel drug target in a variety of human cancers and has consistently been demonstrated to be a critical factor in tumor progression (13). The gene discussed is BIRC5; the disease is cancer.